RxDoctor Payments DataLook up a doctor →

Sarab Alseoudi, MD

Neurology · Newton, KSNPI 1811956998

Payments from drug & device makers

$22,777in general payments, 2019–2025

Across 1,413 payments — averaging $16.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$2K
  • EMD Serono, Inc.$2K
  • Teva Pharmaceuticals USA, Inc.$2K
  • Novartis$1K
  • Biogen$1K
  • AbbVie$1K
  • plus $13K from 53 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sanofi36$2,120
EMD Serono, Inc.118$1,662
Teva Pharmaceuticals USA, Inc.117$1,584
Novartis94$1,449
Biogen117$1,421
AbbVie(2 entities)202$1,169
UCB, Inc.45$1,085
Pfizer68$1,055
Neurocrine Biosciences, Inc.50$994
Genentech USA, Inc.48$801
Amgen(2 entities)30$710
Eisai Inc.21$704
Lundbeck LLC18$690
Lilly USA, LLC49$690
Bristol Myers Squibb41$614
Harmony Biosciences LLC12$450
Supernus Pharmaceuticals, Inc.43$416
Amneal Pharmaceuticals LLC19$370
SK Life Science, Inc.19$365
Sunovion Pharmaceuticals Inc.22$318
AstraZeneca15$317
Jazz Pharmaceuticals Inc.11$272
Biohaven Pharmaceutical Holding Company Ltd.26$245
Acadia Pharmaceuticals Inc11$235
Amylyx Pharmaceuticals, Inc.6$213
Kyowa Kirin, Inc.12$202
Johnson & Johnson(2 entities)4$197
Biohaven Pharmaceuticals, Inc.24$196
Axsome Therapeutics, Inc.8$181
Tanabe Pharma America, Inc.7$179
Avanir Pharmaceuticals, Inc.22$170
Sumitomo Pharma America, Inc.9$150
Zyla Life Sciences, Inc.17$146
Acorda Therapeutics, Inc6$119
Adamas Pharmaceuticals, Inc.7$118
E.r. Squibb & Sons, L.L.C.5$94
Otsuka America Pharmaceutical, Inc.5$92
Argenx US, Inc.3$91
CSL Behring3$76
Boston Scientific4$71
Medtronic(2 entities)2$69
ANI Pharmaceuticals, Inc.4$69
Avion Pharmaceuticals3$68
Ipsen Biopharmaceuticals, Inc4$67
TG Therapeutics, Inc.2$66
Livanova USA, Inc.2$63
Grifols USA, LLC2$50
MDD US Operations, LLC2$44
Corium, LLC3$37
Hospira, Inc.5$37
Assertio Therapeutics, Inc.2$35
Sanofi-aventis U.S. LLC1$24
Catalyst Pharmaceuticals, Inc.1$20
Genentech, Inc.1$18
Upsher-smith Laboratories LLC1$18
Currax Pharmaceuticals LLC1$17
Mallinckrodt Hospital Products Inc.1$17
Xeris Pharmaceuticals, Inc.1$15
GE HealthCare1$15

How this compares

$22,777 in reported general payments places this provider in the 80th percentile of 131 neurology providers in Kansas.

See all neurology providers in Kansas →

Medicare billing

Part B allowed, 2024
$78,403
Medicare patients
366
Services billed
797

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Newton

See the full list for Kansas →

Where these figures come from

Is this you, or does something look wrong? →